Constellation Pharmaceuticals Posts Wider Q1 Net Loss
09:41 AM EDT, 05/10/2021 (MT Newswires) -- Constellation Pharmaceuticals (CNST) reported Monday a wider Q1 net loss of $0.84 per share versus a loss of $0.61 a year ago.
Analysts surveyed by Capital IQ expected a loss of $0.79.
Cash and cash equivalents were $114 million on March 31, down from $163.7 million at the end of December.
The company projects that its current cash, cash equivalents and marketable securities will finance operations into mid-2023.
Price: 20.70, Change: -0.10, Percent Change: -0.48